![Medical News Asia | Powered by ['mediPr]](https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png)
Achieving the Best Outcomes under COVID-19 Endemicity
The first coronavirus (CoV) outbreak occurred as severe acute respiratory syndrome CoV in 2003 in China, followed by the emergence of the Middle East respiratory syndrome CoV in 2012.
Therapeutic advances in non-small cell lung cancer with met exon 14 skipping alterations
At a meeting held on 16th June, 2022, Professor Myung-Ju Ahn from the Department of Haematology and Oncology at Samsung Medical Centre, and Dr Jonathan Nyaw Shi Feng from the Department of Clinical Oncology at Tuen Mun Hospital, presented on the modern treatment for MET exon 14 skipping mutations (METex14+) in non-small cell lung cancer (NSCLC).
Updates on COVID-19 Vaccine Booster in Omicron Era
At a recent webinar organised by the Hong Kong Medical Association on the 24th October 2022, Dr Tsang provided updates on COVID-19 vaccine booster, variant-adapted vaccines and vaccine effectiveness (VE) against long COVID syndromes in Omicron Era.
HK Ocular Surface Newsletter Issue No. 1 Nov 2022
The pathophysiology of dry eye disease (DED) is attributed to a cascade of inflammatory events that results in a vicious circle of immune responses.
